CoverMyMeds (McKesson) vs Humata Health
Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| CoverMyMeds (McKesson) | Humata Health | |
|---|---|---|
| Pricing model | Free to providers (funded by payers/pharma) · Payers, PBMs, pharma fund the network | Enterprise contract (custom) · Priced on volume and workflow complexity |
| Speed to go live | Free self-serve portal; EHR-embedded options exist | EHR-embedded, standard integration project |
| Automation model | Data / network utility · medication ePA network and portal | Autonomous agents · Touchless prior auth, exception-based review |
| Built for | Small practices, Mid-size groups, Enterprise systems, Payers | Mid-size groups, Enterprise systems, Payers |
| Security posture | No certifications published | SOC 2 Type II, HITRUST, HIPAA |
| Company maturity | 18 yrs (est. 2008) | 3 yrs (est. 2023) |
| Financial backing | Subsidiary of McKesson | $25M+ · Series A |
| Named customers | None public | 5 named |
| Published results | No public numbers | No public numbers |
| Documented integrations | 5 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick CoverMyMeds if you want free electronic prior auth for medications with the broadest payer and pharmacy network.
- Pick Humata Health if prior auth volume is drowning your staff and you want touchless submissions inside the EHR with payer-grade compliance credentials.
CoverMyMeds (McKesson)
The largest electronic prior authorization network for medications
- Founded
- 2008
- HQ
- Columbus, OH
- Stage
- Subsidiary of McKesson
- Raised
- n/a
What it does
- Electronic prior authorization for retail and specialty drugs
- Specialty enrollment and hub services (RxLightning)
- Medical benefit PA for oncology and radiology (FastAuth)
- Benefit checks and prescription price transparency
- Patient affordability and copay program delivery
Where it's strong
- Network effects are real: it completed 43 million prior authorizations in the 2025 reverification season and most prescribers already have accounts.
- Free for providers and pharmacies, which makes adoption easy.
- McKesson ownership ties it into specialty distribution and pharma services that competitors cannot match.
What buyers should weigh
- Coverage is payer-dependent and shifting: Independence Blue Cross dropped CoverMyMeds for Surescripts ePA in August 2025, so verify your payer mix routes through it.
- It centers on medication PA; medical benefit and procedure prior auth needs mostly require other tools despite the FastAuth acquisition.
- Its revenue comes from pharma and payers, so provider-side feature priorities can lag.
Integrations
Humata Health
AI prior authorization for providers and payers
- Founded
- 2023
- HQ
- Orlando, FL
- Stage
- Series A
- Raised
- $25M+
What it does
- Matches payer policies to determine if prior auth is required
- Auto-gathers and bundles clinical documentation for submission
- Submits authorizations touchlessly across payer connections
- Monitors auth status and flags changes after submission
- Detects CPT mismatches before submission
- Supports gold-carding and exception-based review workflows
Where it's strong
- Founder Jeremy Friese, MD previously built and sold Verata Health, so this is a second product in the same category, not a first attempt.
- Strategic investors on the payer side (Blue Venture Fund, Optum Ventures, Highmark Ventures) give it unusual payer connectivity for a provider-facing tool.
- Real deployment scale for its age: roughly 225 hospitals and 42,000 physicians, plus CMS selecting it as a technology partner for the WISeR model.
What buyers should weigh
- Headline metrics like 96% first-pass approval and 45% fewer manual touches are vendor-reported, so validate them against your own service lines in a pilot.
- Its role as an AI clinical-review partner in the CMS WISeR model puts it on both the provider and payer sides of prior auth, which some provider organizations may see as a conflict.
- The company traces back to prior authorization assets from Olive AI, which shut down, so diligence which parts of the platform are new versus inherited.
Named customers
Texas Health Resources · Hartford HealthCare · Renown Health · Rochester Regional Health · Lee Health
Integrations
Compare against the rest of Prior Authorization
Deciding between these two?
First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.